Pharmacom Biovet Stock Market Value
| PHMB Stock | USD 0.0001 0.00 0.00% |
| Symbol | Pharmacom |
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pharmacom Biovet. If investors know Pharmacom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pharmacom Biovet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pharmacom Biovet is measured differently than its book value, which is the value of Pharmacom that is recorded on the company's balance sheet. Investors also form their own opinion of Pharmacom Biovet's value that differs from its market value or its book value, called intrinsic value, which is Pharmacom Biovet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pharmacom Biovet's market value can be influenced by many factors that don't directly affect Pharmacom Biovet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pharmacom Biovet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharmacom Biovet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharmacom Biovet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pharmacom Biovet 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharmacom Biovet's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharmacom Biovet.
| 08/30/2024 |
| 11/28/2024 |
If you would invest 0.00 in Pharmacom Biovet on August 30, 2024 and sell it all today you would earn a total of 0.00 from holding Pharmacom Biovet or generate 0.0% return on investment in Pharmacom Biovet over 90 days. Pharmacom Biovet is related to or competes with IMAC Holdings, P3 Health, and HCA Holdings. PharmaCom BioVet, Inc. focuses on operating a network of companion animal cancer treatment centers in the United States More
Pharmacom Biovet Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharmacom Biovet's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharmacom Biovet upside and downside potential and time the market with a certain degree of confidence.
Pharmacom Biovet Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharmacom Biovet's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharmacom Biovet's standard deviation. In reality, there are many statistical measures that can use Pharmacom Biovet historical prices to predict the future Pharmacom Biovet's volatility.Pharmacom Biovet Backtested Returns
We have found three technical indicators for Pharmacom Biovet, which you can use to evaluate the volatility of the company. The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Pharmacom Biovet are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Pharmacom Biovet has perfect predictability. Overlapping area represents the amount of predictability between Pharmacom Biovet time series from 30th of August 2024 to 14th of October 2024 and 14th of October 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharmacom Biovet price movement. The serial correlation of 1.0 indicates that 100.0% of current Pharmacom Biovet price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Pharmacom Biovet lagged returns against current returns
Autocorrelation, which is Pharmacom Biovet stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pharmacom Biovet's stock expected returns. We can calculate the autocorrelation of Pharmacom Biovet returns to help us make a trade decision. For example, suppose you find that Pharmacom Biovet has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pharmacom Biovet regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pharmacom Biovet stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pharmacom Biovet stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pharmacom Biovet stock over time.
Current vs Lagged Prices |
| Timeline |
Pharmacom Biovet Lagged Returns
When evaluating Pharmacom Biovet's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pharmacom Biovet stock have on its future price. Pharmacom Biovet autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pharmacom Biovet autocorrelation shows the relationship between Pharmacom Biovet stock current value and its past values and can show if there is a momentum factor associated with investing in Pharmacom Biovet.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pharmacom Biovet offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pharmacom Biovet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pharmacom Biovet Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pharmacom Biovet Stock:Check out Pharmacom Biovet Correlation, Pharmacom Biovet Volatility and Pharmacom Biovet Alpha and Beta module to complement your research on Pharmacom Biovet. For information on how to trade Pharmacom Stock refer to our How to Trade Pharmacom Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Pharmacom Biovet technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.